News

In collaboration with the Atma Jaya Catholic University of Jakarta, Dexa Group inaugurated the Center for Pharmaceutical and Nutraceutical Research and Policy (CPNRP), a research and policy center under the Atma Jaya University Rectorate. This inauguration is part of Dexa Group's commitment to promoting innovation in the healthcare sector and…

Collaboration between the government, State-Owned Enterprises (SOEs), and the private sector in the health sector plays a crucial role in building a stronger and more equitable national health system and economy. This was the conclusion drawn by speakers at the BNI Investor Daily Summit 2024 during Plenary Session 4, titled…

Integrating Technology in the Pharmaceutical Sector, Dexa Medica Achieves INDI 4.0 Award The innovative efforts of PT Dexa Medica in research and technology development to produce high-quality pharmaceutical products have earned recognition from the government. PT Dexa Medica received the Indonesia Industry 4.0 Readiness Index (INDI 4.0) 2024 award from…

Dexa Group, through PT Dexa Medica, received the Indonesia Halal Industry Award (IHYA) 2024 from the Ministry of Industry (Kemenperin) in the Best Halal Supply Chain category. This award recognizes Dexa Medica's commitment to supporting Indonesia's halal industry ecosystem. The award was presented by Kemenperin’s Secretary-General, Mr. Eko SA Cahyanto,…

Dexa Group received the Indonesia Corporate Social and Environmental Responsibility Award 2024 for Integrating Social Initiatives through Public Health Improvement Programs in the Healthcare Industry category from Warta Ekonomi.co.id. This award was given for Dexa Group's commitment to implementing Corporate Social Responsibility (CSR) within its business activities, which contribute to…

Dexa Group took part in the Pledge Ceremony for Pharmaceutical Industry Maturity, held by Indonesia’s National Agency for Drug and Food Control (BPOM). In his opening remarks, BPOM’s Chief, Mr. Taruna Ikrar, emphasized the agency’s commitment to strengthening compliance within the pharmaceutical industry with existing regulations and standards. "Maturity is…

High blood pressure, high cholesterol, and elevated blood sugar levels can be early signs of chronic diseases such as heart disease, stroke, and diabetes mellitus. To address this, pharmaceutical company Dexa Group, through PT Dexa Medica, urges the public to undergo regular health check-ups to prevent chronic diseases. “We support…